Journal of minimally invasive gynecology
-
J Minim Invasive Gynecol · Sep 2005
Comparative Study Clinical TrialOral and local anesthesia in the nonsurgical radiofrequency-energy treatment of stress urinary incontinence.
To demonstrate the feasibility, safety, and patient comfort associated with nonsurgical radiofrequency-energy (RF) tissue micro-remodeling in women with stress urinary incontinence (SUI) given oral and local anesthesia. ⋯ This pilot trial demonstrated the feasibility, safety, and patient comfort associated with performing a novel new successful technique of nonsurgical RF of the urethra for treatment of SUI, which was previously studied under IV sedation in an outpatient surgery center, on women in an office-based setting using oral plus local anesthesia.
-
J Minim Invasive Gynecol · Jul 2005
Randomized Controlled Trial Clinical TrialEffect of bupivacaine after operative laparoscopic gynecologic procedures.
To evaluate the effect of intraperitoneal installation and periportal infiltration of bupivacaine on postoperative pain and return of bowel function. ⋯ Intraperitoneal installation and periportal infiltration of bupivacaine decrease postoperative pain and hasten the return of bowel function. Both decreased postoperative pain and shortened duration for the return of bowel function are crucial for comfort and discharge of the patient.
-
J Minim Invasive Gynecol · Jul 2005
ReviewTrocar-associated injuries and fatalities: an analysis of 1399 reports to the FDA.
Laparoscopic trocars, medical devices used to gain access into the abdominal cavity, are the most common device named in malpractice injury claims associated with laparoscopic procedures. As part of its ongoing adverse event reporting program, the U. S. ⋯ Further study is needed to evaluate the high proportion of reports associated with laparoscopic cholecystectomy. Laparoscopists should retain for evaluation any devices implicated in patient injuries and should ensure that detailed information on adverse events is provided in adverse event reports to the FDA. The FDA's Manufacturer and User Facility Device Experience (MAUDE) database can be a valuable source for information on adverse outcomes associated with medical devices and, given an understanding of its limitation, provides researchers with a viable adjunct to published literature and litigation surveys for obtaining this information.
-
J Minim Invasive Gynecol · Jul 2005
Randomized Controlled Trial Clinical TrialUse of sublingual buprenorphine for pain relief in office hysteroscopy.
To assess the efficacy of sublingual buprenorphine in the relief of pain associated with office hysteroscopy. ⋯ Office hysteroscopy with a 3.1-mm flexible hysteroscope is a well-tolerated procedure. Sublingual buprenorphine is not helpful in relieving the pain associated with hysteroscopy but is associated with significant adverse reactions.